GlassScriptPhysician profile
Brian Joseph Deyarmin
NPI 1437109543
$490,834.45
in general payments reported to CMS, 2019-2025
82 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80K · 2020: $54K · 2021: $42K · 2022: $81K · 2023: $90K · 2024: $96K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $191K · Travel and Lodging: $19K · Food and Beverage: $15K · Consulting Fee: $9,600 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $191,000.00 |
| Travel and Lodging | $19,006.85 |
| Food and Beverage | $14,761.50 |
| Consulting Fee | $9,600.00 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $464,835.68 | 2019-2025 | Mounjaro, Kisunla, Trulicity |
| Abbvie INC. | $5,608.59 | 2019-2025 | Vraylar, Ubrelvy, Linzess |
| Eli Lilly and Company | $5,146.54 | 2023-2024 | |
| Novo Nordisk INC | $1,616.07 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,355.38 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $1,323.00 | 2019-2025 | Spravato, Xarelto |
| Amgen INC. | $1,172.05 | 2019-2025 | Evenity, Repatha, Krystexxa |
| Pfizer INC. | $1,119.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,027.56 | 2019-2025 | Airsupra, Farxiga, Fasenra |
| Takeda Pharmaceuticals U.S.A., INC. | $633.12 | 2019-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $511.00 | 2019-2025 | Verquvo, Gardasil 9, Vaxneuvance |
| Biohaven Pharmaceutical Holding Company LTD. | $485.69 | 2022 | |
| Allergan, INC. | $444.47 | 2019-2020 | |
| Amarin Pharma, INC. | $401.78 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $385.08 | 2019-2025 | Jardiance, Synjardy |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $365.29 | 2019-2024 | Xifaxan, Trulance |
| Scilex Pharmaceuticals INC. | $286.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $257.69 | 2021-2025 | |
| Abbott Laboratories | $244.08 | 2019-2025 | Freestyle Libre 3, Proclaim |
| E.R. Squibb & Sons, L.L.C. | $192.03 | 2019-2025 | Camzyos, Eliquis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $186.56 | 2023-2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $164.31 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $162.06 | 2022-2025 | Rexulti, Nuedexta |
| Biohaven Pharmaceuticals, INC. | $142.79 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $142.75 | 2019-2024 | Airduo Digihaler, Austedo Xr |
| Ironwood Pharmaceuticals, INC | $128.90 | 2019-2021 | |
| Esperion Therapeutics, INC. | $126.10 | 2020-2025 | Nexletol |
| Ardelyx, INC. | $120.67 | 2024-2025 | Ibsrela |
| Lundbeck LLC | $108.62 | 2022-2025 | Vyepti |
| Kowa Pharmaceuticals America, INC. | $107.21 | 2020-2025 | Zoryve |
| Phathom Pharmaceuticals, INC. | $105.07 | 2024-2025 | Voquezna |
| Corium, LLC | $105.01 | 2022-2025 | Azstarys |
| Astellas Pharma US INC | $91.84 | 2019-2023 | Veozah |
| Sanofi-Aventis U.S. LLC | $90.02 | 2019-2023 | |
| Eisai INC. | $82.77 | 2020-2024 | |
| Sanofi Pasteur INC. | $77.24 | 2020-2025 | |
| Adlon Therapeutics L.P. | $73.06 | 2021 | |
| Upsher-Smith Laboratories LLC | $72.90 | 2020-2021 | |
| Antares Pharma, INC. | $67.07 | 2021-2025 | Xyosted |
| Daiichi Sankyo INC. | $64.43 | 2019-2023 | Injectafer |
| Bioventus LLC | $63.29 | 2021-2024 | Durolane |
| Radius Health, INC. | $62.36 | 2019-2020 | |
| Medtronic Minimed, INC. | $51.52 | 2019-2020 | |
| Axsome Therapeutics, INC. | $51.15 | 2024-2025 | Auvelity |
| Medtronic, INC. | $45.59 | 2022-2024 | Inpen Smart Insulin Delivery System |
| Inspire Medical Systems, INC. | $43.44 | 2025 | Inspire |
| Avanir Pharmaceuticals, INC. | $40.19 | 2019-2021 | |
| Nevro Corp. | $39.67 | 2021 | |
| Gilead Sciences, INC. | $38.14 | 2020-2025 | |
| Jazz Pharmaceuticals INC. | $37.93 | 2019-2020 | |
| Neos Therapeutics, LP | $37.02 | 2022-2023 | Adzenys Xr-Odt |
| Pulmonx Corporation | $36.71 | 2023-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Sunovion Pharmaceuticals INC. | $35.65 | 2021 | |
| Almatica Pharma LLC | $35.12 | 2022 | |
| Tersera Therapeutics LLC | $34.84 | 2019 | |
| Amneal Pharmaceuticals LLC | $33.61 | 2024 | Unithroid |
| Recor Medical INC | $31.05 | 2025 | Paradise Ultrasound Renal Denervation System |
| Dexcom, INC. | $30.99 | 2021-2024 | Dexcom G6 Transmitter |
| Redhill Biopharma INC. | $28.24 | 2020 | |
| Collegium Pharmaceutical, INC. | $25.97 | 2022 | |
| Abiomed | $24.75 | 2023 | Impella |
| Tonix Medicines, INC. | $24.28 | 2025 | Tonmya |
| Halozyme INC | $24.15 | 2023 | |
| Genentech USA, INC. | $23.37 | 2019 | |
| Biodelivery Sciences International, INC. | $23.13 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $22.37 | 2024 | Gvoke Hypopen |
| Argenx US, INC. | $21.47 | 2025 | Vyvgart Hytrulo |
| Si-Bone, INC. | $20.22 | 2022 | |
| Ucb, INC. | $19.70 | 2020 | |
| Idorsia Pharmaceuticals US INC | $18.93 | 2023 | Quviviq |
| Viiv Healthcare Company | $18.88 | 2022 | |
| Exact Sciences Corporation | $17.34 | 2023 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $17.18 | 2019 | |
| Sumitomo Pharma America, INC. | $16.00 | 2023 | Gemtesa |
| Aimmune Therapeutics, INC. | $15.60 | 2024 | |
| Vertical Pharmaceuticals, LLC | $14.90 | 2019 | |
| Verona Pharma, INC. | $14.20 | 2025 | Ohtuvayre |
| Currax Pharmaceuticals LLC | $13.79 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.76 | 2022 | |
| Bausch Health US, LLC | $13.56 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.17 | 2021 | |
| Horizon Therapeutics Plc | $11.46 | 2021 |
Drugs and devices associated with these payments
Mounjaro $207KKisunla $5,288Trulicity $2,750Vraylar $1,820Ubrelvy $1,056Qulipta $959Trelegy Ellipta $496Spravato $421Airsupra $401Linzess $397Farxiga $361Nurtec Odt $336Paxlovid $312Repatha $287Creon $280Otezla $274Fasenra $247Verquvo $243Jardiance $221Eliquis $216Zepbound $207Wegovy $204Xifaxan $199Caplyta $187Trintellix $185Ozempic $179Prolia $179Evenity $179Rybelsus $162Xarelto $157Leqvio $151Kerendia $150Krystexxa $143Rexulti $122Ibsrela $121Voquezna $105Shingrix $105Freestyle Libre 3 $101Azstarys $92.97Breztri $90.72Arexvy $89.45Nexletol $89.44Vyepti $87.13Trulance $85.55Gardasil 9 $84.18Vaxneuvance $84.18Entresto $79.90Proclaim $76.78Evusheld $75.93Xyosted $70.64Zoryve $68.52Vaxelis $68.46Comirnaty $67.69Zavzpret $61.67Fluzone High-Dose $57.19Flublok Quadrivalent Northern Hemisphere $57.19Capvaxive $55.91Veozah $53.81Auvelity $51.15Reyvow $49.13Emgality $49.13Inspire $43.44Viberzi $40.30Rotateq $37.41Zephyr Endobronchial Valve $36.71Zephyr Delivery Catheter $36.71Chartis Catheter $36.71Pulmonx Chartis Tablet Console $36.71Camzyos $34.11Unithroid $33.61Beyfortus $32.89Paradise Ultrasound Renal Denervation System $31.05Injectafer $28.22Belsomra $28.11Durolane $27.50Impella $24.75Tonmya $24.28Tlando $24.15Nuedexta $23.60Inpen Smart Insulin Delivery System $23.36Gvoke Hypopen $22.37Soliqua 100/33 $22.10Vyvgart Hytrulo $21.47Lagevrio $21.38Leqembi $20.88Vyndamax $20.28Quviviq $18.93Gardasil $18.50Dexcom G6 Transmitter $18.36Airduo Digihaler $18.27Bexsero $17.60Pediarix $17.60Rotarix $17.60Cologuard Collection Kit $17.34Austedo Xr $17.23Synjardy $16.73Adzenys Xr-Odt $16.08Gemtesa $16.00Zenpep $15.60Ohtuvayre $14.20
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Deyarmin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.